Medpace Voice

Spotlight on Mexico – Rich in clinical research capabilities and benefits

Mexico is quickly becoming a major player in the pharmaceutical and medical device industries. It’s the number one exporter of medical devices in Latin America and 8th in the world, as well as a leading exporter of pharmaceutical products in Latin America. It’s easy to see why Mexico is a top choice for a clinical research partner.

Read More

How important is patient-centricity in rare disease studies?

Patient-centricity is becoming increasingly important in all areas, but particularly in rare diseases. In this post, Dr. Richard Scheyer discusses the importance of patient-centricity in rare disease studies.

Read More

Medpace Through the Years

This year, Medpace marks its 25th year as a scientifically-driven, global full-service clinical research organization. A lot has changed in the past 25 years. What hasn’t changed is Medpace’s dedication to the mission of accelerating the global development of safe and effective medical therapeutics. In this post, we visually show how we’ve grown from a small group of dedicated people looking for a better way to conduct clinical research to a publicly held, global community of 2,500 employees across 35 countries.

Read More